14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
In Seyfarth’s first installment in its 2020 Trade Secrets Webinar Series, Seyfarth attorneys Robert...
Read More >
Building in part on amendments passed last year, the New York State Legislature has passed legislati...
Read More >
As they once said in This is Spinal Tap, there is a fine line between stupid and clever. I can assur...
Read More >
The Department of Justice (DOJ) has settled and obtained judgements in excess of $2.8 billion for fa...
Read More >
Under the Family and Medical Leave Act of 1993 (FMLA), eligible employees of covered employers are e...
Read More >
A new guidance letter from the Occupational Safety and Health Administration (OSHA) states it is leg...
Read More >